Concomitant coumarin-NSAID therapy and risk for bleeding. - Wikidata - awgldk - TriplyDB

Concomitant coumarin-NSAID therapy and risk for bleeding.

Concomitant coumarin-NSAID therapy and risk for bleeding.

http://www.wikidata.org/entity/Q44263653

about

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting.Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D.Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.Comparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town area Incidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country.Pharmacy students' ability to identify potential drug-drug interactions.Risk factors associated with NSAID-induced upper gastrointestinal bleeding resulting in hospital admissions: A cross-sectional, retrospective, case series analysis in valencia, spain.Prevention and Treatment of NSAID Gastropathy.Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German database.Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies.Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.Major bleeding risk associated with warfarin and co-medications in the elderly population

P2860

Q24632951-96CEBAB8-5D0E-4FE4-8270-2B3BF78BFD02 Q33680181-F907F967-34D6-4BDC-A96A-30C75D895E33 Q33969482-9A841DFF-26B9-4A64-BC2B-E91D4292C6F9 Q34228198-1748746C-3315-44C5-9CBE-637DCB05D651 Q34474985-3E7DD488-0E17-4F0E-8B4C-F8E11F2D82AC Q37077528-57F2781B-6E3E-4659-BB2C-92264B39C301 Q37129099-150857AD-15BF-4765-B3DF-ED1C8DB06734 Q37213516-33977CE8-7E14-43E6-9397-952178E41B88 Q37663470-64B27965-34BA-4696-9C44-8E3370936FCF Q41744470-5E4851BF-7E2B-485C-AA4D-2F804710905E Q43266149-F6F4FA6A-6E48-4458-98A8-EE4090D1E529 Q44848854-093B0759-203D-47BB-A6B7-62E7907CC281 Q45853902-4F99F3DB-1205-478C-BE34-B1646B019B6A Q46721837-F74DD4EB-D3F7-4F6D-BAA8-EE1207F0FBB4 Q57214150-3849A355-46E9-4F91-8042-E579BC31E613

P2860

Concomitant coumarin-NSAID therapy and risk for bleeding.

http://www.wikidata.org/entity/Q44263653

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Concomitant coumarin-NSAID therapy and risk for bleeding.

@en

Concomitant coumarin-NSAID therapy and risk for bleeding.

@nl

type

label

Concomitant coumarin-NSAID therapy and risk for bleeding.

@en

Concomitant coumarin-NSAID therapy and risk for bleeding.

@nl

prefLabel

Concomitant coumarin-NSAID therapy and risk for bleeding.

@en

Concomitant coumarin-NSAID therapy and risk for bleeding.

@nl

P1433

Q44263653-3D1B929D-B3DF-495C-8EF2-403C033BCD2D

P1476

Q44263653-AC1D9E25-960F-4311-847B-5C3A18F9B20A

P2093

Q44263653-2B13A308-5888-4EBA-A9EF-8198F96F6749

Q44263653-36223529-510D-42FF-945D-5FB1F50CF527

Q44263653-7A303529-DFC4-47A9-ABCD-230FAC8374FA

P2860

Q44263653-29BB7FA2-409B-4C95-878E-988FC83FF7BE

Q44263653-2C2C9B27-4C7B-4100-A922-BDF77C9636D3

Q44263653-3A12E923-A2C6-4B14-9BDE-D0B33AF43ACA

Q44263653-3CBDED00-C708-4BBC-8FB9-A5C791E0B625

Q44263653-3FBF7302-91D7-4F2C-8DD6-79D97C2349C1

Q44263653-46072AD6-253D-4DB1-AC17-F1BE52EDD6D7

Q44263653-4F6084A9-6DF0-4049-B89A-18A4CB3FD024

Q44263653-646DF9AF-447C-4324-96F3-FAE037B495B3

Q44263653-786FF720-2EC2-49BD-83F6-58F372914F4C

Q44263653-AAF0B654-0A98-43E0-B758-D6EE52CD31A9

P304

Q44263653-F1F3E4BE-5C33-49AE-9ACD-89CB29EFA04B

P31

Q44263653-A979DC28-1EEB-418F-AE97-DCDF5D2F9CF3

P356

Q44263653-0AD2D77B-DA55-4D94-A9F9-6AE5B6481869

P407

Q44263653-143821DD-D07C-4D75-A3D0-090C7394028D

P433

Q44263653-206EA388-D967-4EB1-94A0-BAD8FD74497A

P478

Q44263653-2A3BBA00-7163-4937-8865-83F783F4CFBF

P577

Q44263653-A1E71F93-ACA8-4CF2-856C-8C66A9C371E8

P698

Q44263653-25FFD703-728D-4E5F-B79F-682C54EA48FE

P356

P1433

Annals of Pharmacotherapy

P1476

Concomitant coumarin-NSAID therapy and risk for bleeding.

@en

P2093

Ellen A J Knijff-Dutmer

http://www.w3.org/2001/XMLSchema#string

Gelte A Schut

http://www.w3.org/2001/XMLSchema#string

Martin A F J van de Laar

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of nonsteroidal anti-inflammatory therapy on platelets.

Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study.

A placebo-controlled study of interaction between nabumetone and acenocoumarol.

Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study.

Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population.

A double-blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone).

New insights into the mode of action of anti-inflammatory drugs.

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population.

Prevalence and characteristics of multiple analgesic drug use in an elderly study group.

P304

12-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1C157

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12503926

http://www.w3.org/2001/XMLSchema#string